Investing, Markets, News SEC Approves New “Oops All IPOs” Stock Index By Alan Khanukaev on November 25, 2020 SEC Approves New “Oops All IPOs” Stock Index
Stock Market Subscription Box Sends New Worthless Penny Stock Every Month Investing, Markets, News Stock Market Subscription Box Sends New Worthless Penny Stock Every Month By Louie Aronowitz on November 24, 2020
STUDY: 32% Of Under 40 COVID Deaths Attributed To Returning Home And Finding Your Mom Threw Out Your Pokemon Cards Investing, News STUDY: 32% Of Under 40 COVID Deaths Attributed To Returning Home And Finding Your Mom Threw Out Your Pokemon Cards By Danny Polishchuk on November 23, 2020
The Next Dave Portnoy? This Man Loves Pizza And Has An Incredibly Punchable Face Investing, News, Opinion The Next Dave Portnoy? This Man Loves Pizza And Has An Incredibly Punchable Face By Jack Stebbins on November 20, 2020
Analyst Upgrades Anheuser-Busch Stock From “Not Good” To “Good Enough” After Friend Gives Them Free Shares Investing, News Analyst Upgrades Anheuser-Busch Stock From “Not Good” To “Good Enough” After Friend Gives Them Free Shares By Louie Aronowitz on November 19, 2020
Bitcoin Traders Propping Up Price By Reminding Everyone How Much Of An Asshole They Felt Like Last Time crypto, Investing Bitcoin Traders Propping Up Price By Reminding Everyone How Much Of An Asshole They Felt Like Last Time By Chris Faga on November 19, 2020
IKEA Stock Sold As Fractional Shares That Investors Can Assemble At Home Investing, Markets, News IKEA Stock Sold As Fractional Shares That Investors Can Assemble At Home By Louie Aronowitz on November 18, 2020
Top 5 Tech Stocks To Invest In Right Now Investing, Opinion, Personal Finance Top 5 Tech Stocks To Invest In Right Now By John W. B. Rich on November 17, 2020
S&P 500 Renamed S&P 808 In Honor Of Tesla’s P/E Ratio Investing, Markets, News S&P 500 Renamed S&P 808 In Honor Of Tesla’s P/E Ratio By Charlie Light on November 16, 2020
Johnson & Johnson Halts Trials After Studies Show Vaccine May Not Be Expensive Investing, Markets, News Johnson & Johnson Halts Trials After Studies Show Vaccine May Not Be Expensive By Jack Stebbins on November 16, 2020
